Life Technologies Advances Gene Regulation Research With Debut of Life Science...

Life Technologies Advances Gene Regulation Research With Debut of Life Science Industry’s First Benchtop Proteomic and Epigenetic Sample Preparation System

MAGic(TM) Sample Processor Eliminates Manual Methodologies, Increases Productivity

CARLSBAD, Calif., Apr 26, 2010 (BUSINESS WIRE) --LifeTechnologies Corporation (NASDAQ:LIFE) today debuted the life science industry’s first benchtop sample preparation system designed to increase productivity while eliminating manual and contamination-related challenges traditionally associated with protein and epigenetic protocols. The Invitrogen MAGic(TM) Sample Processor enables researchers to cut protocol time in half, dramatically reduce experimental errors, and perform technically challenging experiments in protein purification and epigenetics.

Protein purification is a series of processes to isolate a single type of protein from a complex mixture, which is typically a biological tissue or microbial culture. The purification process is critical for characterizing function, structure and interactions of proteins. Research scientists also utilize protein purification in epigenetics to understand how proteins regulate DNA and RNA transcription. While initial applications of the MAGic Sample Processor are in protein isolation and epigenetics, including the isolation of recombinant proteins and immunoprecipitation of large DNA-protein complexes, the system is uniquely flexible to meet a variety of genomic and proteomic applications.

The MAGic Sample Processor houses innovative microfluidics, thermal controls and integrated magnetic separation technology, which allows researchers to easily automate their protein purification and epigenetics methods without relying on centralized facilities. The benchtop system is capable of simultaneously handling 12 samples using a proprietary cartridge to reduce variability commonly attributed with traditional manual approaches, and easily runs standard or customized protocols. Additionally, the system is combined with new reagents based on the company’s leading proprietary Dynabeads (R) magnetic separation technology.

"The MAGic Sample Processor is designed to address reproducibility challenges in research," said Nicolas Barthelemy, President of the Life Technologies Cell Systems Division. "Scientists are under pressure to be more productive and MAGic, along with our other benchtop devices such as the iBlot(TM) Dry Blotting Device and the BenchPro(TM) 4100 Western Processing Device, is enabling researchers to spend less time doing repetitive work and more time where it matters - analyzing their results."

The MAGic Sample Processor is now commercially available.

About Life Technologies ( www.lifetechnologies.com )

Life Technologies Corporation (NASDAQ:LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of $3.3 billion in 2009, employs approximately 9,000 people, has a presence in approximately 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc., and manufactures both in-vitro diagnostic products and research use only-labeled products. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com . Follow Life Technologies on Twitter @LIFECorporation and on Facebook .

SOURCE: Life Technologies Corporation